home.social

#clearoutcomes — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #clearoutcomes, aggregated by home.social.

  1. Stopping in to congratulate @shelbyK88 and Michelle Lim PA-C on @EsperionInc #ClearOutcomes Trial.

    Why we #acc23. Celebrate successes for therapeutics

  2. Stopping in to congratulate @shelbyK88 and Michelle Lim PA-C on @EsperionInc #ClearOutcomes Trial.

    Why we #acc23. Celebrate successes for therapeutics

  3. Stopping in to congratulate @shelbyK88 and Michelle Lim PA-C on @EsperionInc #ClearOutcomes Trial.

    Why we #acc23. Celebrate successes for therapeutics

  4. #clearoutcomes
    🫀subgroups - yay benefit in women
    🫀benefit seen in 1° 👀👍🏾 as well as 2°
    🫀benefit in diabetes 🙌🏾🙌🏾

    Important CVOT adding #BempedoicAcid into the hall of MACE reducing #LLT.
    #acc23 #HeartPA #PhysicianAssociate

  5. #clearoutcomes
    🫀subgroups - yay benefit in women
    🫀benefit seen in 1° 👀👍🏾 as well as 2°
    🫀benefit in diabetes 🙌🏾🙌🏾

    Important CVOT adding #BempedoicAcid into the hall of MACE reducing #LLT.
    #acc23 #HeartPA #PhysicianAssociate

  6. #clearoutcomes
    🫀subgroups - yay benefit in women
    🫀benefit seen in 1° 👀👍🏾 as well as 2°
    🫀benefit in diabetes 🙌🏾🙌🏾

    Important CVOT adding #BempedoicAcid into the hall of MACE reducing #LLT.
    #acc23 #HeartPA #PhysicianAssociate

  7. #clearoutcomes
    🫀N~14k, 70% 2°, 30% 1°
    🫀~22%ish ⬇️LDL-C and ⬇️hsCRP
    🫀RRR 13% 1° MACE endpt
    🫀RRR 15% 3-pt MACE
    #acc23

  8. #clearoutcomes
    🫀N~14k, 70% 2°, 30% 1°
    🫀~22%ish ⬇️LDL-C and ⬇️hsCRP
    🫀RRR 13% 1° MACE endpt
    🫀RRR 15% 3-pt MACE
    #acc23

  9. #clearoutcomes
    🫀N~14k, 70% 2°, 30% 1°
    🫀~22%ish ⬇️LDL-C and ⬇️hsCRP
    🫀RRR 13% 1° MACE endpt
    🫀RRR 15% 3-pt MACE
    #acc23

  10. #clearoutcomes what will we find out?
    🫀up to 20% reported statin intolerance (choice not to use)
    🫀prodrug - activated in liver, low to no peripheral tissue effect (⬇️mm aches)
    🫀4pt- 3pt- MACE
    🫀1°&2° populations
    #acc23

  11. #clearoutcomes what will we find out?
    🫀up to 20% reported statin intolerance (choice not to use)
    🫀prodrug - activated in liver, low to no peripheral tissue effect (⬇️mm aches)
    🫀4pt- 3pt- MACE
    🫀1°&2° populations
    #acc23

  12. #clearoutcomes what will we find out?
    🫀up to 20% reported statin intolerance (choice not to use)
    🫀prodrug - activated in liver, low to no peripheral tissue effect (⬇️mm aches)
    🫀4pt- 3pt- MACE
    🫀1°&2° populations
    #acc23